{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:19:03Z","timestamp":1793344743519,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2018.08.034","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T19:21:26Z","timestamp":1535138486000},"page":"A94-A98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Introduction of intradermal rabies vaccination \u2013 A paradigm shift in improving post-exposure prophylaxis in Asia"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-7569","authenticated-orcid":false,"given":"Gyanendra","family":"Gongal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadey","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2018.08.034_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.08.034_b0010","unstructured":"WHO. Rabies vaccines WHO position paper. Weekly epidemiological report, vol. 85; 2010. p. 309\u201320."},{"key":"10.1016\/j.vaccine.2018.08.034_b0015","unstructured":"WHO expert consultation on rabies. First report. Tech rep series 931. Geneva (Switzerland): World Health Organization; 2005."},{"key":"10.1016\/j.vaccine.2018.08.034_b0020","unstructured":"WHO expert committee on rabies. Tech rep series 824. Geneva (Switzerland); 1992."},{"key":"10.1016\/j.vaccine.2018.08.034_b0025","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/383870","article-title":"Human rabies in the WHO southeast Asia region: forward steps for elimination","author":"Gongal","year":"2011","journal-title":"Adv Prevent Med"},{"key":"10.1016\/j.vaccine.2018.08.034_b0030","unstructured":"WHO. Report of a WHO consultation on intradermal application of human rabies vaccines, Geneva, Switzerland; 1995."},{"key":"10.1016\/j.vaccine.2018.08.034_b0035","unstructured":"WHO. WHO expert consultation on rabies. Second report, tech rep series 982. Geneva (Switzerland): World Health Organization; 2013."},{"key":"10.1016\/j.vaccine.2018.08.034_b0040","unstructured":"WHO. Rabies vaccines and immunoglobulins: WHO position. WHO\/CDS\/NTD\/NZD\/2018.04."},{"key":"10.1016\/j.vaccine.2018.08.034_b0045","unstructured":"WHO. WHO expert consultation on rabies. Third report TRS1012. Geneva (Switzerland): World Health Organization; 2018."},{"key":"10.1016\/j.vaccine.2018.08.034_b0060","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1809.111833","article-title":"Inadequate antibody response to rabies vaccine in immunocompromised patient","volume":"18","author":"Kopel","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.08.034_b0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/14760584.2014.901893","volume":"13","author":"Madhusudana","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.08.034_b0070","first-page":"25","article-title":"Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate ID vaccination design","volume":"351","author":"Teunissen","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8382","key":"10.1016\/j.vaccine.2018.08.034_b0080","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(84)91340-0","article-title":"Multi-site ID and multi-site subcutaneous rabies vaccination: improved economical regimens","volume":"1","author":"Warrell","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2018.08.034_b0085","first-page":"693","article-title":"Antibody response of patients after post-exposure rabies vaccination with small ID doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:43Z","timestamp":1759401283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18311630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":14,"alternative-id":["S0264410X18311630"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction of intradermal rabies vaccination \u2013 A paradigm shift in improving post-exposure prophylaxis in Asia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}